Literature DB >> 20561355

Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine.

Tatsuo Kanda1, Fumio Imazeki, Shingo Nakamoto, Kohichiroh Okitsu, Keiichi Fujiwara, Osamu Yokosuka.   

Abstract

AIM: Little is known about specific naturally-occurring internal ribosomal entry site (IRES) activities of hepatitis A virus (HAV). We examined these activities using the bicistronic reporter assay and the effects of antiviral amantadine against their activities.
METHODS: Six HAV IRES clones from three patients with fulminant hepatitis and three with self-limited acute hepatitis were obtained. The activities of their IRES were analyzed using bicistronic reporter assay in hepatocyte- and non-hepatocyte-derived cell lines, and the potential efficaciousness of the amantadine was examined.
RESULTS: One clone from fulminant hepatitis had a deletion in domains III-IV of HAV IRES had higher IRES activities than HM175 in HLE and Huh-7 cells. In Huh-7 cells, amantadine is effective for inhibiting HAV IRES activities, and especially fulminant hepatitis-derived ones.
CONCLUSION: HAV IRES derived from clinical isolates have various activities. Bicistronic reporter assay using clinical isolates may be another useful tool for testing antiviral activities like those of amantadine and the new acridines and hydrazones recently reported.

Entities:  

Year:  2010        PMID: 20561355     DOI: 10.1111/j.1872-034X.2010.00617.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.

Authors:  Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hiroaki Okamoto; Hirofumi Kogure; Tatsuo Kanda
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

2.  Hepatitis A Virus Infection and Molecular Research.

Authors:  Tatsuo Kanda; Reina Sasaki-Tanaka; Shingo Nakamoto
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

3.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

4.  Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities.

Authors:  Tatsuo Kanda; Sook-Hyang Jeong; Fumio Imazeki; Keiichi Fujiwara; Osamu Yokosuka
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

5.  Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source.

Authors:  Shuang Wu; Shingo Nakamoto; Tatsuo Kanda; Xia Jiang; Masato Nakamura; Tatsuo Miyamura; Hiroshi Shirasawa; Nobuyuki Sugiura; Azusa Takahashi-Nakaguchi; Tohru Gonoi; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2013-12-20       Impact factor: 3.738

Review 6.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 7.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

Review 8.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 9.  Current Practice in Bicistronic IRES Reporter Use: A Systematic Review.

Authors:  Guus Gijsbertus Hubert van den Akker; Federico Zacchini; Bas Adrianus Catharina Housmans; Laura van der Vloet; Marjolein Maria Johanna Caron; Lorenzo Montanaro; Tim Johannes Maria Welting
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 10.  Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.

Authors:  Marion Migueres; Sébastien Lhomme; Jacques Izopet
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.